Endpoints News
healthCenter
Sanofi-backed Electra files for IPO to fund Phase 2/3 immunology drugtranslating…
Biotech's IPO summer isn't over yet.
Electra Therapeutics plans to begin public trading on the Nasdaq after the Labor Day holiday, according to a Friday IPO filing with securities regulators. While ...
Keywords#IPO#Electra#Phase#Sanofi-backed#Sanofi-backed Electra